P Krawitz Md P.c. | |
755 Park Avenue, Suite 100, Huntington, NY 11743-3972 | |
(631) 223-0400 | |
(631) 421-2689 |
Full Name | P Krawitz Md P.c. |
---|---|
Type | Facility |
Speciality | Ophthalmology |
Location | 755 Park Avenue, Huntington, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720019565 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Secondary |
207W00000X | Ophthalmology | (* (Not Available)) | Secondary |
207W00000X | Ophthalmology | 166763-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
P Krawitz Md P.c. 755 Park Avenue, Suite 100, Huntington, NY 11743-3972 Ph: (631) 223-0400 | P Krawitz Md P.c. 755 Park Avenue, Suite 100, Huntington, NY 11743-3972 Ph: (631) 223-0400 |
News Archive
Robust and widespread antibody testing has emerged as a key strategy in the fight against SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.
Playing the stock market can be a risky game. And when the market behaves unpredictably, public fear can lead to erratic investment responses and market chaos.
› Verified 3 days ago